MDLN (Health Care Supplies) Stock Valuation & Fair Value Significantly overvalued
MDLN (Health Care Supplies) trades at a blended P/E of 26.4, about 10% below its historical normal valuation, with a forward growth estimate of 10.0% and a PEG of 2.65.
Valuation flags
- No notable valuation flags.
Frequently asked questions
Is MDLN overvalued?
At a blended P/E of 26.4 versus its historical normal P/E of 29.4, MDLN trades about 10% below its typical valuation, with a PEG of 2.65 on 10.0% forward growth. tickerseer currently rates it significantly overvalued.
What is MDLN's fair value and PEG?
MDLN trades at a blended P/E of 26.4 against a historical normal P/E of 29.4, a PEG of 2.65, and a forward growth estimate of 10.0%.
Has tickerseer's rating of MDLN changed?
tickerseer's rating has been significantly overvalued since 2026-07-31.
Industry: Health Care Supplies. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in the paid plan.
It's free, and you can unsubscribe any time. Educational content, not investment advice.